`

SciNeuro Pharmaceuticals

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$100.0M
size-icon Size
11 - 50

Frequently Asked Questions About SciNeuro Pharmaceuticals

What does Scineuro pharmaceuticals do?+

SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration neurovascular inflammation, proteinopathy, and immune response. The company aims to develop disease-modifying treatment options for Alzheimers disease, Parkinsons disease, and other devastating CNS diseases

What is Scineuro pharmaceuticals's industry? +

Scineuro pharmaceuticals operates in the Biotechnology research industry.

What is Scineuro pharmaceuticals's revenue? +

Scineuro pharmaceuticals's revenue is 11m - 100m

What is Scineuro pharmaceuticals's company size? +

Scineuro pharmaceuticals has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.